Exelixis, Inc. Share Price
NASDAQ: EXEL | Large CapExelixis, Inc. Stock Performance
Exelixis, Inc. Share Price Today
As of 31 October 2026, Exelixis, Inc.'s share price is $69.38. The stock opened at $68.08, compared to its previous close of $66.20. During today's trading session, Exelixis, Inc.'s share price traded between $67.25 and $72.05, with an average price of $69.65. Over the past 52 weeks, the stock has recorded a high of $72.05 and a low of $36.16. In terms of performance, Exelixis, Inc.'s share price has risen by 56.00% over the last six months and is up 79.50% on a year-on-year basis.
Exelixis, Inc. Share Price Chart
Exelixis, Inc. Quarterly Profit & Loss
All figures in USD
Exelixis, Inc. Annual Profit & Loss
All figures in USD
About Exelixis, Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Exelixis, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $58.29 | $69.38 | +18.72% |
Sep 2026 | $55.09 | $58.44 | +5.76% |
Aug 2026 | $52.81 | $55.26 | +4.17% |
Jul 2026 | $54.34 | $53.05 | -2.48% |
Jun 2026 | $50.68 | $54.40 | +7.73% |
May 2026 | $44.06 | $50.49 | +13.54% |
Apr 2026 | $42.91 | $44.47 | +3.68% |
Mar 2026 | $41.95 | $42.89 | -2.62% |
Feb 2026 | $41.85 | $44.05 | +6.52% |
Jan 2026 | $43.52 | $41.35 | -5.62% |
Dec 2025 | $43.62 | $43.81 | -0.80% |
Nov 2025 | $37.77 | $44.16 | +14.27% |